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Abstract
Sensitivity and specificity of rapid antigen detection tests (RADTs) for detection of groupA hemolytic streptococcus (GAS) vary.
The purpose is to present the first SKUP (Scandinavian evaluation of laboratory equipment for point of care testing) evaluations
concerning the assessment of the diagnostic performance and user-friendliness of two RADTs for detection of GAS when used
under real-life conditions in primary health care. Throat samples were collected in duplicates at primary health care centers
(PHCCs) from patients with symptoms of pharyngitis. The performance of QuickVue Dipstick Strep A test (307 samples) and
DIAQUICK Strep A Blue Dipstick (348 samples) was evaluated using culture results at a clinical microbiology laboratory as
comparison. The user-friendliness was evaluated using a questionnaire. The diagnostic sensitivity was 92% (90% confidence
interval (CI) 87–96%) and 72% (90% CI 65–79%), while the diagnostic specificity was 86% (90% CI 81–90%) and 98% (90%
CI 96–99%) for QuickVue Dipstick Strep A test and DIAQUICK Strep A Blue Dipstick, respectively. Both RADTs obtained
acceptable assessments for user-friendliness and fulfilled SKUP’s quality goal for user-friendliness. The diagnostic sensitivity for
QuickVue Dipstick Strep A test and the diagnostic specificity for DIAQUICK Strep A Blue Dipstick in this objective and
supplier-independent evaluation were higher compared with previous meta-analyses of RADTs. However, the diagnostic spec-
ificity for QuickVue Dipstick Strep A test and the diagnostic sensitivity for DIAQUICK Strep A Blue Dipstick were lower
compared with previous meta-analyses of RADTs.
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Introduction
Group A hemolytic streptococcus (Streptococcus pyogenes;
S. pyogenes) (GAS) is the most frequent bacterial cause of
infectious pharyngitis. GAS is estimated to account for 20 to
40% of cases of pharyngitis in children and 5 to 15% in adults
[1, 2]. Common signs and symptoms of the disease include
sore throat, fever, tonsillar exudates, and swollen cervical
lymph nodes. Diagnosis based on clinical features alone is
difficult because symptoms of bacterial pharyngitis overlap
with those of viral pharyngitis. The Norwegian guidelines
for primary health care on streptococcal pharyngitis recom-
mend using rapid antigen detection tests (RADTs) for GAS in
patients fulfilling at least two of the four Centor criteria (fever,
anterior cervical lymphadenopathy, tonsillar rubor and exu-
dates, and lack of cough) [3, 4]. In the Danish guidelines,
two or more of the modified Centor criteria [5] must be ful-
filled [6], while the Swedish guidelines recommend usage of
RADTs upon clinical suspicion of bacterial pharyngitis and
fulfillment of three or four Centor criteria [7]. Antibiotics are
recommended if positive RADT [4, 6, 7].
There are numerous RADT methods [8], and sensitivity
and specificity vary [8–11]. The most widespread and
used RADTs in clinical practice are based on enzyme
immunoassay (EIA) methodology, also known as
immunochromatographic or lateral-flow assays. For these
tests, the diagnostic sensitivity and specificity vary be-
tween 59 and 100% and between 54 and 100%, respec-
tively [8, 11]. In addition to the method, several factors
influence the performance of RADTs, such as duration of
symptoms, disease severity, adequacy, and quality of the
specimen, as well as the test operator [12–14]. Thus, it is
important that the performance is evaluated by the
intended user.
Scandinavian evaluation of laboratory equipment for point
of care testing (SKUP) is a collaboration between the
Scandinavian countries Sweden, Norway, and Denmark.
The purpose of SKUP is to improve the quality of near-
patient testing in Scandinavia by providing objective and
supplier-independent information about analytical quality
and user-friendliness of laboratory equipment [15]. SKUP
generates this information by organizing evaluations which
follow guidelines complied by SKUP. The analytical quality,
diagnostic performance, and user-friendliness are assessed ac-
cording to pre-set quality goals. The user-friendliness survey
is an important satisfaction tool, which could help the users in
choice of RADTs. Since no performance criteria for RADTs
are specified in guidelines, the quality goal set by SKUP is
based on previous results as well as expert opinions [16–18].
SKUP has evaluated 11 in vitro diagnostic RADTs for detec-
tion of GAS since 2003 [15]. The first nine focused on eval-
uation of analytical performance only and did not include
evaluation of the diagnostic performance by the intended
users. Reports from all SKUP evaluations are available on
SKUPs homepage [15]. This paper presents the first SKUP
evaluations concerning the assessment of the diagnostic accu-
racy performance and user-friendliness of two RADTs for
GAS, QuickVue Dipstick Strep A test and DIAQUICK
Strep A Blue Dipstick, when used under real-life conditions
by the intended users in primary health care.
Material and methods
In these prospective studies, data from two SKUP evaluations
of RADTs for GAS were used. The tests were QuickVue
Dipstick Strep A test (Quidel Corporation, San Diego,
California, USA) (SKUP/2015/107) [15] and DIAQUICK
Strep A Blue Dipstick (DIALAB GmbH, Neudorf, Austria)
(SKUP/2018/114) [15] (referred to as QuickVue and
DIAQUICK, respectively, throughout this paper), and the
evaluations were performed in 2015 and 2018, respectively
[15]. An ethical approval for the evaluations was not neces-
sary because the evaluations were considered as quality assur-
ance projects. The Standards for Reporting Diagnostic
Accuracy (STARD) list [19] has been followed.
Recruitment of patients
Consecutive patients with severe symptoms of pharyngitis
seeking care in primary health care centers (PHCCs) in
Skåne county (Sweden) were asked if they were willing to
participate in the study. In this region, there is a low risk of
serious complications caused by GAS [7]. In the evaluation of
QuickVue, seven PHCCs recruited patients from February to
March 2015, and in the evaluation of DIAQUICK, four
PHCCs recruited patients from February to April 2018.
Participation was voluntary and verbal consent was consid-
ered to be sufficient (for patients < 18 years, a parent also
needed to consent). The patients were included by the
Centor criteria [3] where the patient is assessed on four
criteria, with one point added for each positive criterion: (1)
history of fever (> 38.0 °C), (2) tonsillar exudates, (3) tender
anterior cervical adenopathy, and (4) absence of cough.
Individuals with pharyngitis suspected to be bacterial by the
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physician or nurse and fulfilled at least two of the Centor
criteria were included in the study. This is according to the
Norwegian guidelines [4]. Exclusion criteria were antibiotic
treatment during the last 14 days, due to the risk of false-
positive results.
Handling of the samples and measurements with the
RADTs
QuickVue and DIAQUICK are lateral-flow immunoassays
detecting antigen from both viable (true positive) and nonvi-
able (false positive) organisms of S. pyogenes directly from
human throat swabs or culture colonies within 5 min.
Assistant nurses and biomedical laboratory scientists (BLSs)
in the participating PHCCs were trained to use the tests cor-
rectly by a local retailer. The training reflected the training
normally given by the local retailer to customers. The clinical
information was available to the performers of the RADT.
Throat samples were collected in duplicates by rolling two
swabs over the tonsils simultaneously: one swab for the mea-
surement with the RADT and the other for the comparison
method. The swabs were rubbed together to ensure equal dis-
tribution of sample material before running the tests. One
swab was processed as described in the kit insert for the
RADTs [20, 21]. Three different lots of eachRADTwere used
for the purpose of having an evaluation less sensitive to the
risk of a poor or good batch, but separate lot calculations were
not performed. Reading of the strips was most times per-
formed after 5 min. Strongly positive results were read after
1–4 min. For QuickVue, one was read after 10 min, and six
were read after 6 min. The other swab intended for the com-
parison method was swirled in a tube with transport medium
and kept in a refrigerator (2–8 °C) until it was sent in a cold
box (8–14 °C) to the clinical microbiology laboratory the
same day or for a few samples the following day.
Internal and external analytical quality control for the
RADTs
Internal analytical quality control samples, one negative and
one positive, were included in the test kits for the RADTs. The
producer of the RADTs assigned target values. Control sam-
ples were analyzed every day patient samples were analyzed.
In the evaluation of DIAQUICK, the PHCCs alternated be-
tween a positive and a negative control. In addition, the built-
in control features, such as the appearance of a control line,
were examined for each RADT.
In both evaluations, each PHCC participated in one round
of external quality assessment (EQA) from External Quality
Assurance in LaboratoryMedicine in Sweden (Equalis) which
consisted of three control materials with different concentra-
tions of antigen from non-viable Strep A bacteria. The target
values were assigned by the producer of the control materials
(a clinical microbiology laboratory in Sweden).
User-friendliness of the RADTs
To evaluate the user-friendliness of the RADTs, a question-
naire divided into four sections was used: (1) rating of the ease
of usage of the rapid test, (2) rating of the information in the kit
insert, (3) rating of time factors for the preparation and the
measurement including stability of the tests and internal qual-
ity controls, and (4) rating of performing internal and external
analytical quality controls.
The assistant nurses and BLSs at the PHCCs that used the
RADTs filled in sections 1 and 2 (Tables 3 and 4) at the end of
the evaluation period. SKUP filled in sections 3 and 4
(Tables 5 and 6) in addition to topics marked with gray color
for sections 1 and 2. For each question, there were three given
ratings: unsatisfactory, intermediate, and satisfactory. To
achieve the overall rating satisfactory, the total rating of satis-
factory in all four sections had to be reached.
The comparison method
In the absence of a reference measurement method, culturing
of S. pyogenes in a clinical microbiology laboratory
(Department of Clinical Microbiology, Office for Medical
Service, Region Skåne in Lund, Sweden), was used as com-
parison method. The laboratory is accredited by the Swedish
Board for Accreditation and Conformity Assessment
(Swedac) for culturing of beta hemolytic groups A, C, and G
streptococci. The RADT results were available to the asses-
sors of the comparison method. With a few exceptions, the
culturing started the same day as the sample collection. If the
swab arrived late afternoon, the samples were kept refrigerat-
ed overnight before culturing. The patient samples were cul-
tured once. The samples (30 μL of E-swab-liquid) were
spread on double-layered sheep-blood agar plates (Columbia
II agar, BD) and incubated in an anaerobe environment at 37
°C for 16–20 h. In case of growth of typical colonies with beta
hemolysis, the streptococci were characterized with an agglu-
tination test (Streptex™, Thermo Scientific, Oslo, Norway) to
detect the Lancefield group antigens (A, B, C, G). The results
of RADTwere reported to the laboratory as negative, positive,
or invalid and were ready within 24 h for beta hemolytic
streptococci. The performers of the RADTs were usually in-
formed if the comparison method (culture) results deviated
from the rapid test result.
The trueness of the comparison method (culture) was eval-
uated with EQA results. The EQA samples were provided by
United Kingdom National External Quality Assessment
Service (UK NEQAS). The clinical microbiology laboratory
in Lund showed satisfactory results for culturing of beta
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hemolytic streptococci during the evaluation periods (2014–
2015 for QuickVue and 2018 for DIAQUICK ).
When new batches of agar plates were prepared, an internal
analytical quality control was performed by culture of the
reference strain beta hemolytic group A CCUG 25571, on
some of the new plates.
Statistics and performance specifications
Calculations and statistical analysis were performed with
Microsoft Excel. The intended sample size was estimated
from the presumption of at least 100 true positive results from
consecutively included patients in order to obtain acceptable
confidence interval (CI) for diagnostic sensitivity and speci-
ficity for the RADTs. Based on previous evaluations per-
formed in autumn, winter, or early spring, the prevalence of
GAS was estimated to about 25% in the population tested for
GAS. Thus, the goal was to recruit about 400 patients. The
results of the RADTs achieved in the PHCCs were evaluated
against the results of the culturing of samples from the same
patients in the clinical microbiology laboratory (comparison
method). If results were missing from the comparisonmethod,
the samples were excluded from the calculations.
The diagnostic sensitivity and specificity of the RADTs
were calculated by comparing the test results in the PHCCs
with the results from the clinical laboratory. Estimation of CI
for binomial proportions was performed according to
Adjusted Wald [22].
The performance specifications for diagnostic accuracy set
by SKUP were diagnostic sensitivity > 80% and diagnostic




In total 322 and 351 patients provided samples both for the
RADT method and for the comparison method in the evalua-
tion of QuickVue and DIAQUICK, respectively (Table 1, Fig.
1 a and b). The collection of the throat samples was mainly
reported as easy with no adverse events. Characteristics of the
patients are given in Table 1. In the evaluation of QuickVue, 98
patients (30%) fulfilled two Centor criteria [3], 180 (56%) ful-
filled three or four, and for 42 (13%) patients, there were miss-
ing information about Centor criteria. In the evaluation of
DIAQUICK, 142 patients (41%) fulfilled two Centor criteria,
and the remaining (209, 59%) fulfilled three or four. There
were no indeterminate RADT or comparison method results.
Culture results of 15 of the patient samples were missing in the
evaluation of QuickVue, and three RADT results were missing
in the evaluation of DIAQUICK. Thus, 307 samples were
included in the calculations for QuickVue, and 348 samples
were included in the calculations for DIAQUICK (Fig. 1 a
and b). For patients with negative RADTs and culture results,
there was no information about alternative diagnosis. There
were no technical errors reported for the two RADTs.
Internal and external analytical quality control for the
rapid antigen detection tests
In both evaluations, all measurements of both the positive and
negative internal controls showed correct result (n = 146
QuickVue; n = 142 DIAQUICK). In the EQA, the PHCCs
achieved correct results with the RADTs on all three samples.
Diagnostic sensitivity and specificity
The number of true positive and negative, and false
positive and negative results, as well as diagnostic sen-
sitivity and specificity for QuickVue and DIAQUICK,
are shown in Table 2. The 42 patients with missing
information about Centor criteria were included in the
calculations. Exclusion of these results did not change
the results (data not shown). For DIAQUICK, 16 of the
29 false negative results displayed sparse growth of col-
onies; eight displayed moderate growth of colonies. For
QuickVue, there was no connection between the number
of colonies and the false negative results; sparse, mod-
erate, and abundant growths were among the nine false
negative results. For the samples read after 10 and 6
min, there were both positive and negative results and
no weak positive. One of the four throat samples giving
a group C hemolytic streptococcus (Strep C) positive
culture showed a positive result with QuickVue. All
other Strep C (n = 4) or group G hemolytic streptococ-
cus (Strep G) (n = 11) positive cultures tested negative
with QuickVue. The sample giving a Strep C-positive
culture and a positive result with QuickVue could indi-
cate interference; however, the data set was too small to
draw any final conclusions. Furthermore, the sample
Table 1 Characteristics of the patients that participated in the
evaluations of QuickVue Dipstick Strep A test (performed in 2015) and






n = 317 n = 351
Female, n (%) 183 (57) 197 (56)
Male, n (%) 134 (43) 154 (44)
Median age, year (range) 17 (0.67–86) 18 (0.67–88)
<10 years, n (%) 106 (33%) 129 (37%)
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with the Strep C positive culture showed negative real-
time PCR result [15], which confirms the culturing be-
ing negative for Strep A. Several of the false positive
results also showed negative results with real-time PCR
[15], which indicates that the QuickVue test showing
positive result for the strep C-positive patient was just
a random error. In the evaluation of DIAQUICK, there
were 10 Strep C- and 7 Strep G-positive cultures in
addition to the 105 Strep A-positive cultures. All the
17 Strep C- and G-positive cultures were negative on
DIAQUICK. Thus, none of the false positive results on
DIAQUICK were due to Strep C or Strep G. QuickVue
fulfilled the quality goals set by SKUP for diagnostic
sensitivity, and DIAQUICK fulfilled the quality goals
for diagnostic specificity.
RADT negative (n=183)
No comparison method (n=10)




RADT in primary health care centers (n= 322)
Comparison method negative (n=164)
Final diagnosis
Target condition present (n=0)
Target condition absent (n=164)
Inconclusive (n=0)
RADT positive (n=139)
No comparison method (n=5)
Comparison method positive (n=107)
Final diagnosis
Target condition present (n=107)
Target condition absent (n=0)
Inconclusive (n=0)
RADT negative (n=267)
Potentially eligible patients recruited by four primary health care centers (n= 351 (30+39+74+208))
Eligible patients (n=351)
Results from RADT in primary health
care centers missing (n=3)
RADT in primary health care centers (n= 351)
Final diagnosis
Target condition present (n=0)
Target condition absent (n=238)
Inconclusive (n=0)
RADT positive (n=81)
No comparison method (n=0)
Comparison method positive (n=76)
Final diagnosis
Target condition present (n=76)
Target condition absent (n=0)
Inconclusive (n=0)




Comparison method negative (n=238)
Fig. 1 A modified Standards for
Reporting Diagnostic Accuracy
(STARD) diagram [19] showing
the flow of participants in the
evaluations of a QuickVue
Dipstick Strep A test (performed
in 2015) and b DIAQUICK Strep
A Blue Dipstick (performed in
2018). No RADTs were incon-
clusive. The 42 (13%) patients
with missing information about
Centor criteria in the evaluation of
QuickVue are included. RADT,
rapid antigen detection test;
Comparison method, culturing of
Streptococcus pyogenes in a clin-
ical microbiology laboratory
Table 2 Number of true positive and negative, and false positive and
negative results, diagnostic sensitivity and specificity (including 90%
CI), for QuickVue Dipstick Strep A test (evaluation performed in 2015)








True positive results, n 107 76
False negative results, n 9 29
True negative results, n 164 238
False positive results, n 27 5
Diagnostic sensitivity, % (90% CI) 92% (87–96%) 72% (65–79%)
Diagnostic specificity, % (90% CI) 86% (81–90%) 98% (96–99%)
CI confidence interval
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Rating of user-friendliness of the RADTs
All four sections in the questionnaire about user-friendliness
for both QuickVue and DIAQUICK were rated as satisfactory
(Tables 3, 4, 5, and 6). However, there were three intermediate
ratings by the PHCCs for the ease of usage of the rapid test for
QuickVue and four for DIAQUICK (footnotes in Table 3).
For the information in the kit insert, there were two interme-
diate and one unsatisfactory assessment for QuickVue
(footnotes in Table 4). In addition, there were some positive
comments (Table 4).
Discussion
In these studies, the diagnostic performance and user-
friendliness of two RADTs for GAS were assessed by the
intended user under real-life conditions in primary health care.
The diagnostic sensitivity was 92% (95% CI 87–96%) and
Table 3 Rating of the ease of usage of the rapid tests QuickVue
Dipstick Strep A Test (evaluation performed in 2015) and DIAQUICK
Strep A Blue Dipstick (evaluation performed in 2018) by the primary
health care personnel and the SKUP coordinator. Comments for
intermediate or non-satisfactory assessments, provided by the assistant
nurses and BLSs at the PHCCs that used the RADTs or SKUP, are given
in footnotes (SKUP/2015/107, SKUP/2018/114) [15]
Topic Rating
QuickVue Dipstick Strep A Test DIAQUICK Strep A Blue Dipstick
(n=7 PHCCs) (n=4 PHCCs)
To prepare the test / instrument Satisfactorya Satisfactoryh
To prepare the sample Satisfactorya Satisfactoryh
Application of specimen Satisfactory Satisfactory
Number of procedure step Satisfactory Satisfactory
Instrument / test design Intermediateb,c Satisfactoryh
Reading of the test result Easy Easyi
Sources of errors Satisfactory Satisfactory
Hygiene, when using the test Satisfactory Satisfactory
Size and weight of package Satisfactory Satisfactory
Storage conditions for tests, unopened package Satisfactoryd Satisfactoryj
Storage conditions for tests, opened package Satisfactoryd Satisfactoryj
Environmental aspects: waste handlinge Satisfactoryf Satisfactoryk
Intended usersg Satisfactory Satisfactory
Total rating by SKUP Satisfactory Satisfactory
a It was difficult to get the right amount of reagent, often too much (when squeezing the bottles by mistake). One intermediate assessment for each of the
two topics
b The test rack in paper was unstable, would have liked racks in plastic instead. One intermediate assessment
c The disposable packages with the dipsticks were difficult to open. One unsatisfactory assessment
d + 15 °C to + 30 °C
eViable bacteria always have to be handled with special precautions.
f Sorted waste
g Health care personnel or patients
h The diameter of the extraction tube is too small, making it difficult to put drops and swab into it. Difficult to take out the single-packed test sticks. One
intermediate assessment for each of the three topics
i A bit too weak lines sometimes. One intermediate assessment
j + 2 °C to + 30 °C (SKUP rates + 15 °C to + 30 °C as satisfactory)
k Special precautions
Positive comment for QuickVueDipstick Strep A test: Easy to work with, even for inexperienced personnel. Positive comments for DIAQUICK Strep A
Blue Dipstick: Satisfactory test functions, good size package.
Topics marked in bold were rated by SKUP
BLS biomedical laboratory scientist, PHCCs primary health care centers, RADT rapid antigen detection test, SKUP Scandinavian evaluation of
laboratory equipment for point of care testing
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72% (95% CI 65–79%), while the diagnostic specificity was
86% (95% CI 81–90%) and 98% (95% CI 96–99%) for
QuickVue and DIAQUICK, respectively. Both QuickVue
and DIAQUICK obtained acceptable assessment for user-
friendliness and thus fulfilled SKUPs quality goal. Very few
studies have previously reported results for user-friendliness
for RADTs [23].
Table 4 Rating of the information in the kit insert for the rapid tests
QuickVue Dipstick Strep A test (evaluation performed in 2015) and
DIAQUICK Strep A Blue Dipstick (evaluation performed in 2018) by
the primary health care personnel and the SKUP coordinator. Comments
for intermediate or non-satisfactory assessments, provided by the assistant
nurses and BLSs at the PHCCs that used the RADTs or SKUP, are given
in footnotes (SKUP/2015/107, SKUP/2018/114) [15]
Topic Rating
QuickVue Dipstick Strep A Test DIAQUICK Strep A Blue Dipstick
(n=7 PHCCs) (n=4 PHCCs)
General impression Satisfactorya Satisfactory
Preparations / Pre-analytic procedure Satisfactory Satisfactory
Specimen collection Satisfactoryb Satisfactory
Measurement procedure Satisfactory Satisfactory
Reading of result Satisfactory Satisfactory
Description of the sources of error Satisfactory Satisfactory
Help for troubleshooting Satisfactoryc Satisfactory
Readability / Clarity of presentation Satisfactory Satisfactory
Measurement principle Satisfactory Satisfactory
Available insert in Danish, Norwegian, Swedish Satisfactory Intermediated
Total rating by SKUP Satisfactory Satisfactory
a A bit difficult to evaluate a short insert (2 pages), but do not miss any information beside the ones given below. One intermediate assessment
b There were no illustrations for specimen collection. One unsatisfactory assessment
cWould like the contact information to be more visible, and also an e-mail address to be included. One intermediate assessment
d Not available in Danish
Positive comments for QuickVue Dipstick Strep A test: easy to understand, good illustrations, simple language, and laminated quick guide. No technical
errors or failed measurements were reported.
Topics marked in bold were rated by SKUP
BLS biomedical laboratory scientist, PHCCs primary health care centers, RADT rapid antigen detection test, SKUP Scandinavian evaluation of
laboratory equipment for point of care testing
Table 5 Rating of time factors for the preparation and the measurement
including stability of the rapid tests QuickVue Dipstick Strep A test
(evaluation performed in 2015) and DIAQUICK Strep A Blue Dipstick
(evaluation performed in 2018) and internal quality controls by the SKUP
coordinator (SKUP/2015/107, SKUP/2018/114) [15]
Topic Time Rating of both RADTs
QuickVue Dipstick Strep A test DIAQUICK Strep A Blue Dipstick
Required training time < 2 h <2 h Satisfactory
Durations of preparations/pre-analytical time < 6 min <6 min Satisfactory
Duration of analysis < 10 min < 10 min Satisfactory
Stability of test, unopened package > 5 months >5 months Satisfactory
Stability of test, opened packagea > 30 days > 30 day or disposable Satisfactory
Stability of quality control material, unopened > 5 months > 5 months Satisfactory
Stability of quality control material, opened > 6 days or disposable > 6 days or disposable Satisfactory
Total rating by SKUP Satisfactory
a The stability of the reagent solutions does not change when opened. Dipsticks are individually packed and opened right before use
RADT rapid antigen detection test, SKUP Scandinavian evaluation of laboratory equipment for point of care testing
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For QuickVue, the diagnostic sensitivity in the present
study was higher than pooled estimates obtained from meta-
analysis for EIA (85% (95% CI 83–88%) for children [8] and
86% (95% CI 81–91%) for adults [10]), and fulfilled SKUPs
quality goal for diagnostic sensitivity (> 80%). The diagnostic
specificity for QuickVue, however, is lower than the pooled
specificity in meta-analysis for EIA for children (96%, 95%
CI 95–97%) and for adults (97%, 95% CI 96–99%) [10]) and
from that reported by the manufacturer of the test (94%, 95%
CI 91–97%) [20]. QuickVue did not fulfill the quality goal set
by SKUP for diagnostic specificity (> 95%). However, the
specificity of QuickVue in our study was within the range of
reported specificity for EIA (54–100%) [8, 11]. In our evalu-
ation of QuickVue, 18 of the 27 (66%) false positive results
were from two sites representing 39% (121/309) of all tests.
The remaining five sites accounted for 33% (9/27) of the false
positive, representing 61% of the samples, giving a diagnostic
specificity of 92%. In addition, of the 27 false positive results,
five (18%) were reported as weakly positive (weak test line)
by the PHCCs. Thus, user specific performance may partly
explain the low specificity obtained for QuickVue in our
study. Time to culture could also lead to “false positive” re-
sults since GAS does not survive at 4 °C [24] and may affect
the result of the culture. Anyhow, in the evaluations, the stan-
dard procedure for sending throat samples to a laboratory for
culturing used in primary health care was followed.
For DIAQUICK, the diagnostic specificity in the present
study was higher than pooled estimates frommeta-analysis for
EIA for children (96%, 95% CI 95–97%) [8] and for adults
(97%, 95% CI 96–99%) [10]), and fulfilled SKUPs quality
goal for diagnostic specificity (> 95%). The five false positive
results for DIAQUICK were from one site, but we have no
information whether these were weakly positive or not. The
site accounted for about 60% of the samples (208/351)
representing 39% (121/309) of all tests.
The diagnostic sensitivity for DIAQUICK in our study,
however, is lower than the pooled sensitivity in meta-
analysis for EIA in children (85%, 95% CI 83–88%) [8] and
adults (86%, 95% CI 81–91%) [10]), and did not fulfill
SKUPs quality goal for diagnostic sensitivity (> 80%). The
diagnostic sensitivity is also lower than reported by the man-
ufacturer of the test (97%, 95% CI 91–99%) [21], and in a
prospective study from 2008 that was performed in an outpa-
tient setting with children (95.8%) [25]. However, that study
had several limitations including unclear description of the
comparison method, and they used an older version of the
DIAQUICK. Anyway, the diagnostic sensitivity of
DIAQUICK in our study was within the range of reported
sensitivity for EIA (59–96%) [9]. Since the evaluations were
performed in a region with low risk of serious complications
caused by GAS, a low sensitivity is a lesser problem.
The laboratory staff were informed about the results of the
RADTs. This may have introduced the opportunity for bias in
the examination and interpretation of the cultures, which
could have a slight impact on the figures for sensitivity and
specificity.
There is no global consensus for the quality goal for diag-
nostic sensitivity and specificity for RADTs since the impor-
tance of these parameters varies in different parts of the world.
This might contribute to the wide range of diagnostic sensi-
tivity for different RADTs. In high-income countries the risk
of serious complications caused by GAS is low and healthcare
focus on minimizing inappropriate use of antibiotics. High
sensitivity might result in detection of GAS carriers and un-
necessary treatment. Thus, high diagnostic specificity is more
important than high sensitivity. The performance criteria set
by SKUP for RADTs are based on previous studies performed
in Scandinavian countries [16–18], and are also in line with
the pooled estimates for diagnostic sensitivity and specificity
from meta-analysis [9, 10]. Nevertheless, in the meta-analy-
ses, there was great heterogeneity with a high variability in
methodology for the included studies, and the authors disclose
that they do not have strong confidence in the estimates due to
high heterogeneity of the included studies [9, 10].
Some studies indicate that the sensitivity of RADTs vary
with the spectrum of disease [12, 26–28], and an increased
number of modified Centor criteria [5] has been shown to be
associated with increased RADT sensitivity [12, 28].
Table 6 Rating of performing internal and external analytical quality control of the rapid tests QuickVueDipstick StrepA test (evaluation performed in
2015) and DIAQUICK Strep A Blue Dipstick (evaluation performed in 2018) by the SKUP coordinator (SKUP/2015/107, SKUP/2018/114) [15]
Topic Rating
QuickVue Dipstick Strep A test DIAQUICK Strep A Blue Dipstick
Reading of the internal quality control a Satisfactory Satisfactory
Usefulness of the internal quality control Satisfactory Satisfactory
External quality control Satisfactory Satisfactory
Total rating by SKUP Satisfactory Satisfactory
a In addition to the positive and negative controls included in the kit, several procedural control steps are built into the test
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However, in a meta-regression, there were no significant as-
sociations between clinical severity (assessed by modified
Centor criteria [5]) and sensitivity and/or specificity of the
RADTs [8]. In our study, the same percentage of the patients
(almost 60%) had three or four Centor criteria in the evalua-
tion of both QuickVue and DIAQUICK. QuickVue did fulfill
SKUPs criteria for diagnostic sensitivity, and the diagnostic
sensitivity did not change after exclusion of patients with only
two Centor criteria (data not shown). Thus, the low sensitivity
for DIAQUICK can probably not be explained by that a rela-
tively high proportion of the patients had only two Centor
criteria.
There is also a risk of false negative results from culturing
and RADTs if the amount of secretion obtained from the
throat samples is too small, and studies have shown that the
sensitivity of RADTs increased considerable with inoculum
size [13, 14]. In our evaluation of DIAQUICK, more than
83% of the false negative results displayed sparse or moderate
growth of colonies which may indicate small amount of secret
in the samples and may, thus, contribute to the low sensitivity.
For culturing, there is additional risk for obtaining upper re-
spiratory tract normal flora when collecting the throat samples
resulting in false negative results. Culture performance is also
affected by the conditions used for plating and incubation of
the cultures [29], and there is no consensus on the details in the
methods for culture of S. pyogenes. In our study, the cultures
were performed in an accredited laboratory, and all results
from the internal and external analytical quality control were
satisfactory. Anyway, if the comparison method is either rel-
atively insensitive or too sensitive, the performance of RADT
may be evaluated erroneously. Neither the RADTs nor cultur-
ing, or any other methods, are able to distinguish between
patients who are carriers of GAS and those who are actually
infected with GAS.
In our study, about one third of the patients were < 10 years
of age. However, this did probably not affect the results since
meta-analysis found that the sensitivity and specificity of the
RADTs when analyzed in pediatric studies alone were similar
to the overall estimates [9]. Furthermore, the pooled sensitiv-
ity and specificity found in children and in mixed population
of children and adults are very similar [11].
The prevalence of GAS in the tested population affects the
performance of RADTs. In our studies, the prevalence of GAS
was 38% in the evaluation of QuickVue and 30% in the eval-
uation of DIAQUICK. Used in a population with similar prev-
alence of disease, the positive predictive value (PPV) and the
negative predictive value (NPV) for QuickVue is 80% and
95%, respectively. The corresponding numbers for
DIAQUICK are 94% and 89%, respectively. In a population
with a prevalence of 25% for GAS, the PPV and NPV would
have been 69% and 97%, respectively for QuickVue. For
DIAQUICK, the corresponding numbers are 92% and 41%,
respectively.
The difference of prevalence of GAS in the same popula-
tion in 2015 and 2018 is within the expected variation be-
tween seasons. We have no indication that the prevalence
has been affected by genetic changes leading to altered viru-
lence of Streptococcus pyogenes and prevalence of GAS in-
fections [30].
In conclusion, the diagnostic sensitivities were 92% and
72%, and the diagnostic specificities were 86% and 98% for
QuickVue and DIAQUICK, respectively in primary health
care. Both RADTs obtained acceptable assessments for user-
friendliness and fulfilled SKUPs quality goal for user-friend-
liness. There are several factors that can affect the perfor-
mance of RADTs, and these studies provide an objective
and supplier-independent information about analytical quality
and user-friendliness when used under real-life conditions by
the intended users.
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